Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Drug Metab Rev. 2010 Feb;42(1):133-44. doi: 10.3109/03602530903209049.
Human UDP-glucuronosyltransferases (EC 2.4.1.17) (UGTs) are major phase II metabolism enzymes that detoxify a multitude of endo- and xenobiotics through the covalent addition of a glucuronic acid moiety. UGTs are promiscuous enzymes that regulate the levels of numerous important endobiotics in a range of tissues, and inactivate most therapeutic compounds in concert with phase I enzymes. In spite of the importance of these enzymes, we have only a limited understanding of the molecular mechanisms governing their substrate specificity and catalytic activity. Until recently, no three-dimensional structural information was available for any mammalian UGT. The 1.8-å resolution apo crystal structure of the UDP-glucuronic acid binding domain of human UGT2B7 (2B7CT) is the only structure of a mammalian UGT target determined to date. In this review, we summarize what has been learned about human UGT function from the analysis of this and other related glycosyltransferase (GT) crystal structures.
人类 UDP-葡糖醛酸基转移酶(EC 2.4.1.17)(UGTs)是主要的 II 相代谢酶,通过共价添加葡糖醛酸部分来解毒多种内源性和外源性物质。UGTs 是混合酶,可调节多种组织中大量重要内源性物质的水平,并与 I 相酶一起使大多数治疗化合物失活。尽管这些酶很重要,但我们对其底物特异性和催化活性的分子机制只有有限的了解。直到最近,还没有任何哺乳动物 UGT 的三维结构信息可用。人 UGT2B7(2B7CT)的 UDP-葡糖醛酸结合域的 1.8-Å 分辨率无蛋白晶体结构是迄今为止确定的唯一结构哺乳动物 UGT 靶标。在这篇综述中,我们总结了从分析该结构和其他相关糖基转移酶(GT)晶体结构中了解到的关于人 UGT 功能的知识。